| CatalogCode: | NB100-78126 |
| ProductName: | IL-3 Antibody |
| Product Description: | Rat Monoclonal anti-IL-3 (BVD8-3G11) |
| Clone: | BVD8-3G11 |
| Clonality: | Monoclonal |
| Immunogen: | Yeast-expressed, recombinant human IL-3 |
| CrossReactivity: | Human. |
| Packaging: | 0.5 mg Immunogen affinity purified Rat antisera |
| Uses: | Each lot of this antibody is quality control tested by ELISA assay. For ELISA capture applications, a concentration range of 1-4 mug/ml is recommended. To obtain a linear standard curve, serial dilutions of human IL-3 protein ranging from 2000 to 15 pg/ml are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application. |
| Control: | Erythroid cells, megakaryocytes, neutrophils, eosinophils, basophils, mast cells, monocytic lineage |
| Background: | IL-3 is a highly species-specific pleiotropic factor produced primarily by activated T cells though also by mast cells, keratinocytes, and astrocytes, which stimulates colony formation of megakaryocytes, neutrophils, and macrophages from bone marrow cultures. The BVD8-3G11 antibody can neutralize the bioactivity of natural or recombinant IL-3. |
| Storage: | Store at 4C. Do not freeze. |
| Purity: | Immunogen affinity purified |
| Isotype: | IgG1, kappa |
| Host_Name: | Rat |
| Buffer: | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| ListPrice: | 285 |
| AppSummary: | ELISA, IP, WB |
| SpeciesSummary: | Hu |
| ALTnames: | anti-Interleukin-3 antibody, anti-Burst promoting activity (BP/BPA) antibody, anti-Eosinophil colony stimulating factor (Eo-CSF) antibody, anti-Hematopoietic cell growth factor (HCGF) antibody, anti-Mast cell growth factor (MGF/MCGF) antibody, anti-Multi-colony stimulating factor (Multi-CSF) antibody, anti-P cell stimulating activity (PCSA) antibody |
| ProteinTarget: | IL-3 |
| PackageSize: | 0.5 mg |
| GeneralRef: | 1. Fitzgerald, K., et al., Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego. 2. Frendl, G., 1992. Int. J. Immunopharmacol. 14:421. 3. Ihle, J., 1992. Chem. Immunology 51:65. |
|